semaglutide and heart Cuts Risk Beyond Weight Loss: Study Insights into semaglutide cardiovascular research:

Results: GLP-1RAs attenuate inflammation by suppressing NF-B and p38 MAPK pathways, reduce oxidative stress, enhance insulin sensitivity, and promote mitochondrial and endothelial stability

2016 Jan

These include: Fatigue, weakness, and pallor are the most common symptoms that appear in the early stages

In addition, long-term use of GLP-1RAs may also have potential safety risks, such as pancreatitis (Shetty et al., 2022) and thyroid diseases ( 6 Discussion T2DM is a chronic disease characterized by hyperglycemia, which eventually leads to microvascular damage and macrovascular events, as well as complications related to peripheral vascular diseases

Schopman JE, Simon AC, Hoefnagel SJ, Hoekstra JB, Scholten RJ, Holleman F

Additionally, Ivy Rx provides an online program for guidance and support, making it easier for you to stay on track with your weight loss journey